Literature DB >> 10930971

Pharmacokinetics and tolerability of intravenous infusion of adenosine (SUNY4001) in healthy volunteers.

T Uematsu1, O Kozawa, H Matsuno, M Niwa, H Yoshikoshi, M Oh-uchi, K Kohno, S Nagashima, M Kanamaru.   

Abstract

AIMS: To examine the tolerability and disposition of i.v. adenosine (SUNY4001) in healthy male Japanese volunteers.
METHODS: SUNY4001 was infused i.v. for 6 min at 0 (placebo), 60, 100, 120 and 140 microg kg-1 min-1 in a dose-escalating manner in 30 healthy subjects. Adenosine and its metabolites were determined in the plasma and urine.
RESULTS: Only plasma hypoxanthine was increased from 3 min during until 5-10 min after SUNY4001 infusion at the higher rates without any significant dose-related changes in plasma adenosine, inosine, xanthine or uric acid, or in urinary adenosine and all metabolites compared with the placebo. There was a dose-related increase in the incidence of subjective symptoms such as heat sensation, flushed face, dyspnoea, chest discomfort, etc. Transient and self-subsiding episodes of second-degree atrioventricular block were found in two subjects each at the higher doses.
CONCLUSIONS: Adenosine infusion at < or = 140 microg kg-1 min-1 was concluded to be generally well tolerated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930971      PMCID: PMC2014395          DOI: 10.1046/j.1365-2125.2000.00214.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Myocardial uptake and clearance of T1-201 in healthy subjects: comparison of adenosine-induced hyperemia and exercise stress.

Authors:  P A Siffring; N C Gupta; S M Mohiuddin; D J Esterbrooks; D E Hilleman; S C Cheng; M H Sketch; M P Frick
Journal:  Radiology       Date:  1989-12       Impact factor: 11.105

2.  Effects of adenosine on human coronary arterial circulation.

Authors:  R F Wilson; K Wyche; B V Christensen; S Zimmer; D D Laxson
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

3.  Atrial fibrillation induced by adenosine triphosphate.

Authors:  B Belhassen; A Pelleg; D Shoshani; S Laniado
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

4.  Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial.

Authors:  P C Albro; K L Gould; R J Westcott; G W Hamilton; J L Ritchie; D L Williams
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

5.  Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry.

Authors:  M D Cerqueira; M S Verani; M Schwaiger; J Heo; A S Iskandrian
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

6.  A simple and sensitive radioimmunoassay for adenosine.

Authors:  R Yamane; T Nakamura; E Matsuura; H Ishige; M Fujimoto
Journal:  J Immunoassay       Date:  1991

7.  Dipyridamole inhibition of adenosine metabolism in human blood.

Authors:  R E Klabunde
Journal:  Eur J Pharmacol       Date:  1983-09-16       Impact factor: 4.432

8.  Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance.

Authors:  L Belardinelli; G Isenberg
Journal:  Am J Physiol       Date:  1983-05

9.  Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease.

Authors:  A Abreu; J J Mahmarian; S Nishimura; T M Boyce; M S Verani
Journal:  J Am Coll Cardiol       Date:  1991-09       Impact factor: 24.094

10.  Effects of dipyridamole on myocardial adenosine and active hyperemia.

Authors:  R M Knabb; J M Gidday; S W Ely; R Rubio; R M Berne
Journal:  Am J Physiol       Date:  1984-11
View more
  5 in total

Review 1.  Purines, the carotid body and respiration.

Authors:  S Lahiri; C H Mitchell; D Reigada; A Roy; N S Cherniack
Journal:  Respir Physiol Neurobiol       Date:  2007-02-24       Impact factor: 1.931

2.  Activation of nicotinic ACh receptors with alpha4 subunits induces adenosine release at the rat carotid body.

Authors:  Sílvia V Conde; Emília C Monteiro
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

Review 3.  Purines and Carotid Body: New Roles in Pathological Conditions.

Authors:  Silvia V Conde; Emilia C Monteiro; Joana F Sacramento
Journal:  Front Pharmacol       Date:  2017-12-12       Impact factor: 5.810

4.  Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.

Authors:  Sanja Cicko; Melanie Grimm; Korcan Ayata; Jessica Beckert; Anja Meyer; Madelon Hossfeld; Gernot Zissel; Marco Idzko; Tobias Müller
Journal:  Respir Res       Date:  2015-09-15

5.  Effect of High (200 μg/kg per Minute) Adenosine Dose Infusion on Fractional Flow Reserve Variability.

Authors:  Dimitrios Alexopoulos; Ioanna Xanthopoulou; Grigorios Tsigkas; Nikolaos Koutsogiannis; Paraskevi Salata; Stylianos Armylagos; Athanasios Moulias; Periklis Davlouros
Journal:  J Am Heart Assoc       Date:  2016-11-10       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.